Access1 Access2 Access3 Medication & Drugs Muscles & Joints March 17, 2022 Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)
Access1 Access2 Access3 Medication & Drugs Nervous System March 11, 2022 Fremanezumab (Ajovy): Migraines – A True Pain to Treat
Access1 Access2 Access3 Infectious Disease Medication & Drugs March 3, 2022 Paxlovid (Nirmatrelvir and Ritonavir) by Pfizer – A Game-changer in the COVID-19 Treatment Landscape?
Access1 Access2 Medication & Drugs February 24, 2022 Singapore’s HSA New Drugs and Indications Approval – Jan 2022
Access1 Access2 Access3 Medication & Drugs Skin February 17, 2022 HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)
Infectious Disease Medication & Drugs February 8, 2022 Current Oral Drugs Available for COVID-19 Treatment
Access1 Access2 Access3 Medication & Drugs Nervous System Uncategorized February 2, 2022 Eptinezumab (Vyepti) for preventive treatment of both episodic and chronic migraine
Access1 Access2 Medication & Drugs January 25, 2022 Singapore’s HSA New Drugs and Indications Approval – Dec 2021
Infectious Disease Medication & Drugs January 25, 2022 Molnupiravir for COVID-19? 5 Things You Need To Know About This Oral Drug
Access1 Access2 Access3 Medication & Drugs Skin January 20, 2022 The growing biologic armamentarium of plaque psoriasis treatment: A review of risankizumab (Skyrizi)